• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?

作者信息

Filippi Massimo, Margoni Monica, Zaccone Tiziana, Guerrieri Simone, Rancoita Paola Maria, Moiola Lucia, Rocca Maria Assunta

机构信息

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.

出版信息

J Neurol. 2024 Dec 12;272(1):9. doi: 10.1007/s00415-024-12788-1.

DOI:10.1007/s00415-024-12788-1
PMID:39666135
Abstract
摘要

相似文献

1
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?基于扩展残疾状态量表的多发性硬化症残疾恶化结局：0.5分有影响吗？
J Neurol. 2024 Dec 12;272(1):9. doi: 10.1007/s00415-024-12788-1.
2
Long-term worsening of different body functions in persons with progressive multiple sclerosis.进行性多发性硬化症患者不同身体功能的长期恶化。
Mult Scler J Exp Transl Clin. 2020 Oct 13;6(4):2055217320964514. doi: 10.1177/2055217320964514. eCollection 2020 Oct-Dec.
3
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.鞘内免疫球蛋白 G 合成与多发性硬化症残疾恶化的关联。
JAMA Neurol. 2019 Jul 1;76(7):841-849. doi: 10.1001/jamaneurol.2019.0905.
4
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.复发缓解型多发性硬化症患者残疾恶化的检测：来自意大利多发性硬化症登记处的真实世界扩展残疾状态量表参考分析。
Eur J Neurol. 2021 Feb;28(2):567-578. doi: 10.1111/ene.14589. Epub 2020 Nov 6.
5
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study.颈脊髓灰质损伤预示着多发性硬化症患者残疾程度的恶化：一项纵向研究。
J Neurol. 2025 Feb 25;272(3):228. doi: 10.1007/s00415-025-12979-4.
6
Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.脑深部灰质和丘脑亚核体积损失：多发性硬化残疾进展的纵向研究。
J Neurol. 2020 May;267(5):1536-1546. doi: 10.1007/s00415-020-09740-4. Epub 2020 Feb 10.
7
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.综合确认的残疾恶化/进展是多发性硬化症临床试验中一个有用的临床终点。
Neurology. 2025 May 27;104(10):e213558. doi: 10.1212/WNL.0000000000213558. Epub 2025 Apr 21.
8
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症临床试验结果中扩展残疾状态量表、25英尺计时步行测试和九孔插钉测试的比较
Neurology. 2021 Oct 19;97(16):e1560-e1570. doi: 10.1212/WNL.0000000000012690. Epub 2021 Aug 25.
9
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts.复发缓解型多发性硬化症治疗试验中的残疾结局指标：安慰剂队列中疾病进程异质性的影响
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):450-7. doi: 10.1136/jnnp.68.4.450.
10
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies.在接受阿仑单抗治疗的多发性硬化症患者中，6个月时确认的残疾改善和恶化情况与长期残疾结局相关：CARE-MS研究的事后分析
Neurol Ther. 2021 Dec;10(2):803-818. doi: 10.1007/s40120-021-00262-3. Epub 2021 Jun 24.

本文引用的文献

1
Multiple sclerosis diagnosis: a biologically driven perspective.多发性硬化症诊断：生物学驱动视角
Lancet Neurol. 2024 Jul;23(7):668-669. doi: 10.1016/S1474-4422(24)00207-2.
2
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.统一多发性硬化症中与复发活动无关的进展的定义：一项系统评价
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
3
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis.抑郁症状、焦虑和认知障碍：多发性硬化症中的新证据。
Transl Psychiatry. 2023 Jul 19;13(1):264. doi: 10.1038/s41398-023-02555-7.
4
How patients with multiple sclerosis acquire disability.多发性硬化症患者如何致残。
Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016.
5
Ofatumumab versus Teriflunomide in Multiple Sclerosis.奥法妥木单抗与特立氟胺治疗多发性硬化症的比较。
N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246.
6
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.在两项随机临床试验的汇总分析中，复发无关进展与复发相关恶化对典型复发型多发性硬化症总体确认残疾累积的贡献。
JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.
7
Multiple sclerosis.多发性硬化症。
Nat Rev Dis Primers. 2018 Nov 8;4(1):43. doi: 10.1038/s41572-018-0041-4.
8
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断：2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
9
Defining secondary progressive multiple sclerosis.定义继发进展型多发性硬化症。
Brain. 2016 Sep;139(Pt 9):2395-405. doi: 10.1093/brain/aww173. Epub 2016 Jul 7.
10
Defining the clinical course of multiple sclerosis: the 2013 revisions.多发性硬化症临床病程的定义：2013年修订版
Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.